Marianna Nuti

Pubblicazioni

Titolo Pubblicato in Anno
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells ANNALS OF ONCOLOGY 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients JOURNAL OF PERSONALIZED MEDICINE 2020
Bevacizumab-based chemotherapy triggers Immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector T Cell Subsets JOURNAL OF CLINICAL MEDICINE 2019
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? CANCERS 2019
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab JOURNAL OF TRANSLATIONAL MEDICINE 2019
Immune profile of metastatic uveal melanoma during treatment with pembrolizumab JOURNAL OF CLINICAL ONCOLOGY 2019
Immunotherapy in non-small cell lung cancer patients: back to the future RECENTI PROGRESSI IN MEDICINA 2019
HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES DIGESTIVE AND LIVER DISEASE 2019
L’immunoterapia nel tumore del polmone non a piccole cellule: ritorno al futuro RECENTI PROGRESSI IN MEDICINA 2019
Anisakis pegreffii impacts differentiation and function of human dendritic cells PARASITE IMMUNOLOGY 2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway CANCER IMMUNOLOGY RESEARCH 2018
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis GYNECOLOGIC ONCOLOGY 2018
The microbiota impact. bacteria shaping immunity, disease and response to therapy TRANSLATIONAL CANCER RESEARCH 2018
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study) BRITISH JOURNAL OF CANCER 2018
The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one CANCER TREATMENT REVIEWS 2018
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? JOURNAL OF TRANSLATIONAL MEDICINE 2018
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells FRONTIERS IN IMMUNOLOGY 2018
Cancer immunotherapy in patients with brain metastases CANCER IMMUNOLOGY, IMMUNOTHERAPY 2018
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment ONCOTARGET 2017

ERC

  • LS2_15
  • LS4_6
  • LS4_12
  • LS6
  • LS6_3
  • LS6_10
  • LS7_2

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Precision Medicine with particular interest in tumor immunology and the identification of mechanisms involved in the tumor- immunity interaction. Development of strategies for the activation of immunity in cancer patients and reduction of immunosuppression. Identification of biomarkers in immunity. Identification and study of the Interactions of drugs and targeted therapy with the immune systems of cancer patiemts. Immunotherapy clinical trials.

Keywords

tumor immunology
precision medicine
anticancer immunotherapy
Cancer vaccines

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma